Literature DB >> 3394110

Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats.

U J Eriksson1.   

Abstract

Previous experimental studies have implicated a genetic component in the induction of malformations in the offspring of diabetic rats. We have compared the outcome of diabetic pregnancy in two outbred (sub)strains of Sprague-Dawley rats (with low incidence [H] and high incidence [U] of skeletal malformations in the offspring) and hybrids between them. The fetuses of diabetic H mothers had no skeletal malformations and the lowest frequency of resorptions (8-9%), regardless of embryo type (H/H or H/U). When the diabetic mother was U or from the hybrid strain (H/U) and the offspring were of the mixed H/U type, we found increased resorption (16-21%) and skeletal malformation (3-5%) rates. If instead the embryos contained a major U genome [either U/U or U/(H/U)], further increased resorptions (23-30%) and skeletal malformations (17-19%) resulted. The H/H and U/U embryonic susceptibility to defined teratogens (3-6 mg/ml D-glucose, 4-8 mM B-hydroxy-butyrate) were compared in whole embryo culture and found to be similar, suggesting that the malformations occurring in vivo may have a different etiology than those found in vitro. In the rat model studied, diabetes in the mother appears to cause a disturbance of early stages of embryogenesis in genetically predisposed embryos. This early disturbance results in skeletal malformations and seems to require inducing factor(s) in addition to increased levels of D-glucose and B-hydroxybutyrate. The findings are in concert with the notion of a mixed genetic-environmental etiology of malformations in (diabetic) pregnancy.

Entities:  

Mesh:

Year:  1988        PMID: 3394110     DOI: 10.1002/tera.1420370410

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  12 in total

Review 1.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  The fetus of the diabetic mother: growth and malformations.

Authors:  I Swenne
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

3.  Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks.

Authors:  Mary R Loeken
Journal:  Mol Genet Metab       Date:  2014-01-25       Impact factor: 4.797

4.  High glucose concentration inhibits migration of rat cranial neural crest cells in vitro.

Authors:  N Suzuki; K Svensson; U J Eriksson
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 5.  Understanding diabetic teratogenesis: where are we now and where are we going?

Authors:  Sheller Zabihi; Mary R Loeken
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

6.  Regionally disturbed production of cartilage proteoglycans in malformed fetuses from diabetic rats.

Authors:  E Unger; U J Eriksson
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

7.  Maternal diabetes in the rat impairs the formation of neural-crest derived cranial nerve ganglia in the offspring.

Authors:  J Cederberg; J J Picard; U J Eriksson
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

8.  Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: effect of short-term blood glucose control in diabetic rats.

Authors:  A Kofoed-Enevoldsen; D Noonan; T Deckert
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

9.  In vitro development of rat embryos obtained from diabetic mothers.

Authors:  E Menegola; M Prati; M L Broccia; R Ricolfi; E Giavini
Journal:  Experientia       Date:  1995-04-15

10.  Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro.

Authors:  U J Eriksson; L A Borg
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.